362 related articles for article (PubMed ID: 12920582)
1. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
Badorff C; Knowlton KU
Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
[TBL] [Abstract][Full Text] [Related]
2. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU
Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
Lee GH; Badorff C; Knowlton KU
Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
[TBL] [Abstract][Full Text] [Related]
4. Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
Badorff C; Lee GH; Knowlton KU
Herz; 2000 May; 25(3):227-32. PubMed ID: 10904843
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
[TBL] [Abstract][Full Text] [Related]
7. CVB infection and mechanisms of viral cardiomyopathy.
Knowlton KU
Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.
Bouin A; Gretteau PA; Wehbe M; Renois F; N'Guyen Y; Lévêque N; Vu MN; Tracy S; Chapman NM; Bruneval P; Fornes P; Semler BL; Andreoletti L
Circulation; 2019 May; 139(20):2326-2338. PubMed ID: 30755025
[TBL] [Abstract][Full Text] [Related]
9. Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy.
Koide H; Kitaura Y; Deguchi H; Ukimura A; Kawamura K; Hirai K
Jpn Circ J; 1992 Oct; 56(10):1081-93. PubMed ID: 1331557
[TBL] [Abstract][Full Text] [Related]
10. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].
Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP
Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414
[TBL] [Abstract][Full Text] [Related]
11. [The expression of dystrophin in human viral myocarditis and dilated cardiomyopathy].
Xu HF; Li YH; Chen Y; Cheng LB
Fa Yi Xue Za Zhi; 2006 Feb; 22(1):12-4. PubMed ID: 16524176
[TBL] [Abstract][Full Text] [Related]
12. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy.
Xiong D; Yajima T; Lim BK; Stenbit A; Dublin A; Dalton ND; Summers-Torres D; Molkentin JD; Duplain H; Wessely R; Chen J; Knowlton KU
Circulation; 2007 Jan; 115(1):94-102. PubMed ID: 17190866
[TBL] [Abstract][Full Text] [Related]
13. Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy.
Grumbach IM; Heim A; Pring-Akerblom P; Vonhof S; Hein WJ; Müller G; Figulla HR
Acta Cardiol; 1999 Apr; 54(2):83-8. PubMed ID: 10378019
[TBL] [Abstract][Full Text] [Related]
14. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue.
Badorff C; Berkely N; Mehrotra S; Talhouk JW; Rhoads RE; Knowlton KU
J Biol Chem; 2000 Apr; 275(15):11191-7. PubMed ID: 10753926
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease.
Xiong D; Lee GH; Badorff C; Dorner A; Lee S; Wolf P; Knowlton KU
Nat Med; 2002 Aug; 8(8):872-7. PubMed ID: 12118246
[TBL] [Abstract][Full Text] [Related]
16. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
Chapman NM; Kim KS
Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
[TBL] [Abstract][Full Text] [Related]
17. Enteroviruses and myocarditis.
Why H
Br J Hosp Med; 1995 May 3-16; 53(9):430-4. PubMed ID: 7613714
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients.
Gaaloul I; Riabi S; Harrath R; Hunter T; Hamda KB; Ghzala AB; Huber S; Aouni M
Mol Med Rep; 2014 Dec; 10(6):2811-8. PubMed ID: 25241846
[TBL] [Abstract][Full Text] [Related]
19. Detection of enteroviral genome and its significance in cardiomyopathy.
Katsuragi M; Yutani C; Mukai T; Arai Y; Imakita M; Ishibashi-Ueda H; Hao H; Nagata S; Miyatake K
Cardiology; 1993; 83(1-2):4-13. PubMed ID: 8261486
[TBL] [Abstract][Full Text] [Related]
20. Genetics of coxsackievirus B3 cardiovirulence.
Tracy S; Tu Z; Chapman N; Hufnagel G
Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
